Michael Mason
2021
In 2021, Michael Mason earned a total compensation of $1.7M as Executive Vice President, Chief Financial Officer and Treasurer at Karyopharm Therapeutics, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $182,000 |
| Option Awards | $681,352 |
| Salary | $444,386 |
| Stock Awards | $370,834 |
| Other | $16,006 |
| Total | $1,744,578 |
Mason received $681.4K in option awards, accounting for 39% of the total pay in 2021.
Mason also received $50K in bonus, $182K in non-equity incentive plan, $444.4K in salary, $370.8K in stock awards and $16K in other compensation.
Rankings
In 2021, Michael Mason's compensation ranked 6,601st out of 12,406 executives tracked by ExecPay. In other words, Mason earned more than 46.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,601 out of 12,406 | 47th |
Division Manufacturing | 2,846 out of 5,494 | 48th |
Major group Chemicals And Allied Products | 1,253 out of 2,369 | 47th |
Industry group Drugs | 1,117 out of 2,090 | 47th |
Industry Pharmaceutical Preparations | 809 out of 1,537 | 47th |
Source: SEC filing on April 8, 2022.
Mason's colleagues
We found five more compensation records of executives who worked with Michael Mason at Karyopharm Therapeutics in 2021.
2021
Richard Paulson
Karyopharm Therapeutics
Chief Executive Officer
2021
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
2021
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
2021
Jatin Shah
Karyopharm Therapeutics
Chief Medical Officer
2021
Ran Frenkel
Karyopharm Therapeutics